Clinical trial / 2015
Organic khorasan wheat improved cardiovascular risk markers in acute coronary syndrome patients.
In a randomized crossover trial, 22 acute coronary syndrome patients consumed cereal products made from organic semi-whole khorasan wheat or modern control wheat for eight weeks each. The khorasan intervention significantly lowered total cholesterol by 6.8%, LDL cholesterol by 8.1%, glucose by 8%, and insulin by 24.6% from baseline. It also reduced reactive oxygen species, tumor necrosis factor-alpha, and lipoperoxidation of circulating monocytes and lymphocytes, whereas control wheat produced no significant changes.
- Study type
- Randomized crossover trial
- Who was studied
- 22 patients with acute coronary syndrome
- What was measured
- Circulating lipid, oxidative, and inflammatory risk markers
THE PAPER
An organic khorasan wheat-based replacement diet improves risk profile of patients with acute coronary syndrome: a randomized crossover trial.
Whittaker A, Sofi F, Luisi ML, Rafanelli E, Fiorillo C, Becatti M, Abbate R, Casini A, Gensini GF, Benedettelli S. Nutrients, 2015.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.